Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
NCT06295835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 232
Last updated 2025-03-19
Summary
Method comparison study for Potassium (K) and ionized calcium (iCa).
Conditions
- Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood
Interventions
- DIAGNOSTIC_TEST
-
Fingerstick blood draw
Capillary blood specimen collected from two separate fingersticks.
Sponsors & Collaborators
-
Abbott Point of Care
lead INDUSTRY
Principal Investigators
-
Manish Gupta, BS, MBA · Abbott Point of Care
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-31
- Primary Completion
- 2025-01-29
- Completion
- 2025-01-29
- FDA Device
- Yes
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Calcium Balance Studies in Children With CKD and on Dialysis
NCT03285854 ·Status: UNKNOWN
-
Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
NCT00004284 ·Status: COMPLETED ·Phase: PHASE3
-
Calcium and Phosphorus Balance and Calcium Kinetics in Patients With Stage 3/4 Chronic Kidney Disease
NCT01161407 ·Status: COMPLETED ·Phase: NA
-
Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease
NCT03108222 ·Status: UNKNOWN
-
Cardiovascular Mortality Associated With Abnormal Calcium Metabolism
NCT00018395 ·Status: COMPLETED
-
Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
NCT00667576 ·Status: COMPLETED ·Phase: PHASE2
-
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
NCT00990704 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)
NCT01020487 ·Status: COMPLETED ·Phase: PHASE3
-
Calcium Concentration in Bicarbonate Hemodialysis (HD)
NCT01353170 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)
NCT00048516 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
NCT02756520 ·Status: COMPLETED
-
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
NCT00048451 ·Status: COMPLETED ·Phase: PHASE3
-
Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study
NCT04207203 ·Status: COMPLETED ·Phase: NA
-
Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)
NCT00701805 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
NCT02163499 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
NCT04942119 ·Status: UNKNOWN ·Phase: NA
-
PTH-independent Effects of Encaleret
NCT05735015 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet
NCT02649205 ·Status: COMPLETED
-
Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney Disease
NCT01071070 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
NCT00646035 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease
NCT00257920 ·Status: COMPLETED ·Phase: PHASE4
-
Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients
NCT00485706 ·Status: COMPLETED ·Phase: NA
-
Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation
NCT06681116 ·Status: COMPLETED ·Phase: NA
-
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice
NCT01083849 ·Status: COMPLETED
-
Bone in CKD Alkali Response (BICARb Pilot Trial)
NCT05918029 ·Status: RECRUITING ·Phase: PHASE2/PHASE3